Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296835 · ClinicalTrials.gov registry record · NA
Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope
A NA study, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT07296835: Recruiting NA study, sponsored by University of Kansas Medical Center.
NCT07296835 is a NA study that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07296835, a NA study, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
Comprehensive comparative investigations between HugeMed HU30M 6.3 Fr f-URS and traditional approach f-URS devices in RIRS are lacking in an American population. The investigators aim to compare the outcomes of using the 6.3 Fr f-URS versus traditional approach (other f-URS present in our institution) to treat patients with stone burden ≤ 2.5 cm. The findings of this study will expand on the potential advantages and drawbacks of HU30M in enhancing surgical outcomes and patient safety in RIRS procedures. We hypothesize that the use of the HU30M will result in increased cost savings while providing similar stone free rates when compared to traditionally used f-URS devices.
Primary Outcome
Stone free rate, defined as the absence of residual stone fragments \> 2 mm, as determined by noncontrast CT scan performed
Interventions
- DEVICE Ureteroscopy using the 6.3 Fr f-URS hugemed
- DEVICE Hugemed 6.3 Fr f-URS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-11 |
| Phase | NA |
What NCT07296835 shows while recruiting
NCT07296835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Ureteroscopy using the 6.3 Fr f-URS hugemed is the first listed.
NCT07296835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07296835 about?
NCT07296835 is a clinical study titled "Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope". Comprehensive comparative investigations between HugeMed HU30M 6.3 Fr f-URS and traditional approach f-URS devices in RIRS are lacking in an American population. The investigators aim to compare the outcomes of using the 6.3 Fr f-URS versus traditional approach (other f-URS present in our institutio...
What is the current status of trial NCT07296835?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-05-01. Estimated completion is 2028-11.
What interventions are being tested in trial NCT07296835?
The interventions under investigation include: Ureteroscopy using the 6.3 Fr f-URS hugemed (DEVICE), Hugemed 6.3 Fr f-URS (DEVICE).
Who is sponsoring clinical trial NCT07296835?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07296835's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI